Literature DB >> 6169802

Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

A Biber, D Englert, D Dommasch, K Hempel.   

Abstract

Cerebrospinal fluid (CSF) from 105 patients was analyzed by radioimmunoassay for the presence of material cross-reactive with peptide 89-169 of bovine myelin basic protein (BP). In a group of 72 multiple sclerosis patients, 52 showed higher BP content than the control group, i.e. more than 2 ng/ml CSF. Increased BP or BP fragments could be detected in CSF from almost all patients who recently (within 2 weeks) had had an acute episode, or after deterioration in the progressive form of the disease. Fifteen to 30 days after the onset of exacerbation or in a stable period, BP content decreases and in the slowly progressive form was in the range of the control group with one exception. BP content was also elevated in the CSF of patients with other neurological diseases. The presence of BP in the CSF from patients with isolated retrobulbar neuritis is of particular interest. Thus the presence of material cross-reactive with BP fragment 89-169 is not specific for multiple sclerosis, but is a useful parameter in diagnosis and evaluation of MS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169802     DOI: 10.1007/BF00313295

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Degradation of myelin basic protein by cerebrospinal fluid: preservation of antigenic determinants under physiological conditions.

Authors:  E C Alvord; S Hruby; L R Sires
Journal:  Ann Neurol       Date:  1979-12       Impact factor: 10.422

2.  Radioimmunoassay of myelin basic protein in sodium sulfate.

Authors:  E D Day; O M Pitts
Journal:  Immunochemistry       Date:  1974-10

3.  Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.

Authors:  M L Cuzner; A N Davison; P Rudge
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

4.  Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.

Authors:  J H Carson; E Barbarese; P E Braun; T A McPherson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

6.  Spinal fluid differences in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  H S Gutstein; S R Cohen
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

7.  Radioimmunoassay of CSF for encephalitogenic basic protein: a diagnostic test for MS?

Authors:  T A McPherson; A Gilpin; T P Seland
Journal:  Can Med Assoc J       Date:  1972-11-04       Impact factor: 8.262

8.  Increase in myelin basic protein in CSF after brain surgery.

Authors:  C Alling; B Karlsson; B Vällfors
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

9.  [Myelin basic protein in cerebrospinal fluid in neurosyphilis (author's transl)].

Authors:  H Prange; A Kohlschütter; G Ritter
Journal:  Dtsch Med Wochenschr       Date:  1980-08-08       Impact factor: 0.628

10.  Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.

Authors:  J N Whitaker; R P Lisak; R M Bashir; O H Fitch; J M Seyer; R Krance; J A Lawrence; L T Ch'ien; P O'Sullivan
Journal:  Ann Neurol       Date:  1980-01       Impact factor: 10.422

View more
  10 in total

Review 1.  Cerebrospinal fluid markers in neurological disorders.

Authors:  A R Massaro; G Scivoletto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1990-12

2.  Myelin basic protein in Fisher syndrome.

Authors:  J Matias-Guiu; A Ruibal; J Alvarez; M Fraile; J M Martinez-Vazquez
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

3.  Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.

Authors:  R Crols; J Saerens; M Noppe; A Lowenthal
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

4.  Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity.

Authors:  N R Hoyle; R T Pratt; D G Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

5.  Immunocytochemical localization of cell type-specific markers in reaggregating cell cultures of mouse cerebellum.

Authors:  J Lindner; M Schachner
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

6.  Myelin basic protein in the cerebrospinal fluid of patients infected with HIV.

Authors:  H W Pfister; K M Einhäupl; M Wick; A Fateh-Moghadam; M Huber; E Schielke; F D Goebel; A Matuschke; B Heinrich; J R Bogner
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

Review 7.  Myelin basic protein and multiple sclerosis.

Authors:  J N Whitaker
Journal:  Ital J Neurol Sci       Date:  1983-06

8.  Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome and lymphocytic meningoradiculitis by isoelectric focusing.

Authors:  H Krüger; D Englert; K W Pflughaupt
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

9.  Myelin basic protein immunoreactivity in serum of neurosurgical patients.

Authors:  D G Thomas; N R Hoyle; P Seeldrayers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

Review 10.  Multiple sclerosis: neuroimmunologic puzzle.

Authors:  B P Barna
Journal:  Clin Lab Med       Date:  1986-03       Impact factor: 1.935

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.